Ten Year Follow-up in FSHD: the FOCUS 3 Study

This study aims to assess longitudinal data in 170 adult and 30 pediatric genetically and clinically well-defined facioscapulohumeral dystrophy (FSHD) patients. FSHD is a chronic progressive disorder ...

Lead sponsor: Radboud University Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Eline Boon, MD

CONTACT

0686550949 eline.tm.boon@radboudumc.nl

Nicol Voermans, MD, PhD

CONTACT

0650155770 nicol.voermans@radboudumc.nl

Related studies

COMPLETEDNA

High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy

NCT02159963 · FSHD - Facioscapulohumeral Muscular Dystrophy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 4, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment200

Start dateSep 2024

Last updatedApr 4, 2025

Condition

FSHD - Facioscapulohumeral Muscular Dystrophy

Locations shown

Radboudumc

Nijmegen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 4, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions